Drug can delay progression of low-risk prostate cancer, lower men's anxiety: study

TORONTO - A class of drug long used to treat prostate enlargement appears to have benefits for men diagnosed with low-risk, localized prostate cancer — delaying disease progression and reducing patients' anxiety, a Canadian-led international study has found....More